Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines

CL Trotter, ME Ramsay

Research output: Contribution to journalArticle (Academic Journal)peer-review

127 Citations (Scopus)

Abstract

At the end of 2005, six European countries had implemented public immunisation campaigns with serogroup C conjugate vaccines to date and all had experienced substantial declines in the incidence of serogroup C disease. A quadrivalent ACWY meningococcal vaccine is in use in the USA, but serogroup A is extremely rare in Europe and serogroups Y and W-135 are infrequent causes of disease. This paper outlines recommendations about the use of conjugate vaccines in Europe, based on the experience with MCC vaccines so far.
Translated title of the contributionVaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines
Original languageEnglish
Pages (from-to)101 - 107
Number of pages7
JournalFEMS Microbiology Reviews
Volume31 (1)
DOIs
Publication statusPublished - Jan 2007

Bibliographical note

Publisher: Blackwell

Fingerprint Dive into the research topics of 'Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines'. Together they form a unique fingerprint.

Cite this